Home > Financial Ratios > BAL PHARMA

BAL PHARMA
EBIT Growth

    Back to All Ratios
BAL PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 43.52-15.0823.562,138.47-106.36

What is the latest EBIT Growth ratio of BAL PHARMA ?

The latest EBIT Growth ratio of BAL PHARMA is 43.52 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202443.52
Mar2023-15.08
Mar202223.56
Mar20212,138.47
Mar2020-106.36

How is EBIT Growth of BAL PHARMA Trending?

Years EBIT Growth % Change
Mar2024 43.52
Positive
Mar2023 -15.08
Negative
Mar2022 23.56
-98.90
Mar2021 2138.47
Positive
Mar2020 -106.36 -

Other Financial Ratios of BAL PHARMA


Compare EBIT Growth ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹163.9 Cr -7.8% 10.4% 4.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,032.0 Cr 0.9% 2.2% 23.9% Stock Analytics
DIVIS LABORATORIES ₹162,252.0 Cr 3.3% 4.7% 58% Stock Analytics
CIPLA ₹124,457.0 Cr 0.5% 2% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,425.0 Cr -0.4% 2.8% 24.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,152.8 Cr -0.8% -0.4% 0.8% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-7.8%

10.4%

4.6%

SENSEX

0.9%

3%

8.9%


You may also like the below Video Courses